TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Jacobio Pharmaceuticals Group Co., Ltd. ( (HK:1167) ) has shared an announcement.
Jacobio Pharmaceuticals Group Co., Ltd. announced its intention to conduct an on-market share repurchase of up to 78,873,528 shares, representing 10% of its issued shares, using up to HK$100 million from its financial resources. This move is aimed at enhancing the value of its shares and reflects the company’s confidence in its long-term business prospects and growth potential, ultimately benefiting shareholders.
The most recent analyst rating on (HK:1167) stock is a Hold with a HK$3.70 price target. To see the full list of analyst forecasts on Jacobio Pharmaceuticals Group Co., Ltd. stock, see the HK:1167 Stock Forecast page.
More about Jacobio Pharmaceuticals Group Co., Ltd.
Jacobio Pharmaceuticals Group Co., Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company focuses on the development and commercialization of innovative drugs, with a market presence on the Main Board of The Stock Exchange of Hong Kong Limited.
Average Trading Volume: 6,159,921
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.74B
For a thorough assessment of 1167 stock, go to TipRanks’ Stock Analysis page.